These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31686090)

  • 1. Editorial: Can Digital Technology Advance the Development of Treatments for Alzheimer's Disease?
    Mc Carthy M; Schueler P
    J Prev Alzheimers Dis; 2019; 6(4):217-220. PubMed ID: 31686090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review.
    Piau A; Wild K; Mattek N; Kaye J
    J Med Internet Res; 2019 Aug; 21(8):e12785. PubMed ID: 31471958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital biomarkers from geolocation data in bipolar disorder and schizophrenia: a systematic review.
    Fraccaro P; Beukenhorst A; Sperrin M; Harper S; Palmier-Claus J; Lewis S; Van der Veer SN; Peek N
    J Am Med Inform Assoc; 2019 Nov; 26(11):1412-1420. PubMed ID: 31260049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force.
    Kaye J; Aisen P; Amariglio R; Au R; Ballard C; Carrillo M; Fillit H; Iwatsubo T; Jimenez-Maggiora G; Lovestone S; Natanegara F; Papp K; Soto ME; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2021; 8(4):513-519. PubMed ID: 34585227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital technologies for cognitive assessment to accelerate drug development in Alzheimer's disease.
    Leurent C; Ehlers MD
    Clin Pharmacol Ther; 2015 Nov; 98(5):475-6. PubMed ID: 26272508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart Home-based IoT for Real-time and Secure Remote Health Monitoring of Triage and Priority System using Body Sensors: Multi-driven Systematic Review.
    Talal M; Zaidan AA; Zaidan BB; Albahri AS; Alamoodi AH; Albahri OS; Alsalem MA; Lim CK; Tan KL; Shir WL; Mohammed KI
    J Med Syst; 2019 Jan; 43(3):42. PubMed ID: 30648217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of daily walking activity and gait profiles: a novel application of a time series analysis framework.
    Buckley C; McArdle R; Galna B; Thomas A; Rochester L; Del Din S
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():2482-2485. PubMed ID: 31946401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications and Outcomes of Internet of Things for Patients with Alzheimer's Disease/Dementia: A Scoping Review.
    Sheikhtaheri A; Sabermahani F
    Biomed Res Int; 2022; 2022():6274185. PubMed ID: 35342749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extending the Passive-Sensing Toolbox: Using Smart-Home Technology in Psychological Science.
    Nelson BW; Allen NB
    Perspect Psychol Sci; 2018 Nov; 13(6):718-733. PubMed ID: 30217132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's Disease.
    Reed C; Happich M; Raskin J; Tockhorn-Heidenreich A; Belger M
    J Prev Alzheimers Dis; 2019; 6(2):90-99. PubMed ID: 30756115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial.
    Lipsmeier F; Taylor KI; Kilchenmann T; Wolf D; Scotland A; Schjodt-Eriksen J; Cheng WY; Fernandez-Garcia I; Siebourg-Polster J; Jin L; Soto J; Verselis L; Boess F; Koller M; Grundman M; Monsch AU; Postuma RB; Ghosh A; Kremer T; Czech C; Gossens C; Lindemann M
    Mov Disord; 2018 Aug; 33(8):1287-1297. PubMed ID: 29701258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a seniors and Alzheimer's disease caring service platform.
    Lee CW; Chuang HM
    BMC Med Inform Decis Mak; 2021 Nov; 21(Suppl 10):273. PubMed ID: 34781953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal exercise intervention improves frontal cognitive functions and gait in Alzheimer's disease: a controlled trial.
    Coelho FG; Andrade LP; Pedroso RV; Santos-Galduroz RF; Gobbi S; Costa JL; Gobbi LT
    Geriatr Gerontol Int; 2013 Jan; 13(1):198-203. PubMed ID: 22686565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Biomarkers in Alzheimer's Disease Drug Development.
    Cummings J
    Adv Exp Med Biol; 2019; 1118():29-61. PubMed ID: 30747416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.
    Egan MF; Kost J; Tariot PN; Aisen PS; Cummings JL; Vellas B; Sur C; Mukai Y; Voss T; Furtek C; Mahoney E; Harper Mozley L; Vandenberghe R; Mo Y; Michelson D
    N Engl J Med; 2018 May; 378(18):1691-1703. PubMed ID: 29719179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease.
    Wattmo C; Blennow K; Hansson O
    BMC Neurol; 2020 Jan; 20(1):10. PubMed ID: 31918679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
    Doody RS; Thomas RG; Farlow M; Iwatsubo T; Vellas B; Joffe S; Kieburtz K; Raman R; Sun X; Aisen PS; Siemers E; Liu-Seifert H; Mohs R; ;
    N Engl J Med; 2014 Jan; 370(4):311-21. PubMed ID: 24450890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smartphone-based ecological momentary assessment and intervention in a coping-focused intervention for hearing voices (SAVVy): study protocol for a pilot randomised controlled trial.
    Bell IH; Fielding-Smith SF; Hayward M; Rossell SL; Lim MH; Farhall J; Thomas N
    Trials; 2018 May; 19(1):262. PubMed ID: 29720208
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.